• Home
  • Technology
  • Product Pipeline
  • Our Company
  • IP & Publications
  • 75% of CDI occurs in nursing homes and outpatient facilities... Let's diagnose CDI where it occurs.
  • Severe CDI has a 28% mortality rate... Let's make a difference saving lives.
  • CDI deaths increased 400% between 2000 and 2007... Let's change it.
  • Severe CDI costs up to $100,000 per case... Let's reduce the costs.
  • Last-line antibiotics need defending... Let's provide a new tool.

Revolutionary Molecular Diagnostic Tests from Lenima

Lenima offers revolutionary, groundbreaking molecular testing that can be brought to the point of care. The heart of Lenima's molecular diagnostic tests is a revolutionary piezoelectric plate sensor (PEPS) based on a novel thin crystalline material that allows unsurpassed sensitivity, simplifying the genetic testing process, permitting rapid and simultaneous testing of multiple nucleic acids including both DNAs and RNAs in a simple, elegant, portable, and low-cost format.

 
Home Contact us